Synonyms:oxyphenbutazone, 129-20-4, Oxyphenylbutazone, Tandearil, Oxazolidin, Tanderil, Oxifenylbutazon, Oxiphenbutazone, Butapirone, Crovaril, Flamaril, Flogitolo, Flogoril, Rapostan, Visubutina, Frabel, Oxalid, Oxyphenobutazone, p-Oxyphenylbutazone, Oxi-Fenibutol, Neo-Farmadol, Artroflog, Butaflogin, Butanova, Butazonic, Butilene, Californit, Deflogin, Etrozolidina, Flanaril, Floghene, Flogistin, Flogodin, Flogostop, Flopirina, Idrobutazina, Infammil, Ipabutona, Isobutazina, Isobutil, Offitril, Oxibutol, Oxybuton, Oxyphentamin, Pirabutina, Piraflogin, Poliflogil, Tandacote, Tandalgesic, Tendearil, Flogal, Infamil, Iridil, Mysite, Neofen, Optimal, Remazin, Reumox, Rumapax, Telidal, Valioil, Metabolite I, Oxazolidin-Geigy, p-Hydroxyphenylbutazone, Oxiphenbutazonum, Usaf Ge-14, Hydroxyphenylbutazon, Oxifenbutazona, Tanderal, Oxyphenbutazonum, Oxyphenbutazone [INN], 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, Oxyphenbutazone anhydrous, BM 1, 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine, 1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione, 4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione, 4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione, Suganril, 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE, 4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine, 4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione, 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine, 3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene, G 27202, Oxyphenyl butazone, 3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-, MLS003373849, Flegmostam, Oxazolioin, Reunabutal, Aradinum, Butanora, DTXSID1045291, Portoril, Telidac, CHEBI:76258, Genal, A7D84513GV, Cinophen-N, NSC-526053, Oxyphenbutazone (INN), 1-(p-Hydroxyphenyl)-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine, Ossifenbutazone [DCIT], AB00052064_08, G-29701, DTXCID9025291, Oxifenbutazona [INN-Spanish], Oxyphenbutazonum [INN-Latin], Ossifenbutazone, OPB, CCRIS 6717, HSDB 3144, SR-05000001689, EINECS 204-936-2, 1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine, NSC 526053, BRN 0307474, metabolitie, Romaxin, Reozon, UNII-A7D84513GV, AI3-26792, 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl, NCGC00016389-01, CAS-129-20-4, Reozon (TN), Decanoylm-nitroaniline, Oxyphenbutazone (TN), Spectrum_001073, Oxyphenbutazone, Tanderil, Prestwick0_001049, Prestwick1_001049, Prestwick2_001049, Prestwick3_001049, Spectrum2_000153, Spectrum3_000535, Spectrum4_001155, Spectrum5_000998, CHEMBL1228, OXYPHENBUTAZONE [MI], SCHEMBL25857, BSPBio_000978, BSPBio_002149, KBioGR_001729, KBioSS_001553, DivK1c_000302, OXYPHENBUTAZONE [HSDB], SPECTRUM1500455, SPBio_000286, SPBio_002909, BPBio1_001076, OXYPHENBUTAZONE [WHO-DD], HMS500P04, HY-B1355A, KBio1_000302, KBio2_001553, KBio2_004121, KBio2_006689, KBio3_001649, NINDS_000302, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione, BDBM200298, HMS1571A20, HMS1920D20, HMS2091L20, HMS2098A20, HMS2236G07, HMS3373B01, HMS3715A20, Pharmakon1600-01500455, BCP20014, Tox21_110414, 3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (VAN), CCG-38944, NSC526053, NSC757261, AKOS024362800, Tox21_110414_1, DB03585, IDI1_000302, (+/-)-OXYPHENBUTAZONE ANHYDROUS, NCGC00094748-01, NCGC00094748-02, NCGC00094748-03, NCGC00094748-04, NCGC00094748-07, (+/-)-Oxyphenbutazone-d9(N-butyl-d9), MS-24837, SBI-0051471.P003, OXYPHENBUTAZONE ANHYDROUS, (+/-)-, 3, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-, AB00052064, CS-0013099, FT-0673468, RO-04-4410, WLN: T5VNNV EHJ BR DQ & CR & E4, 3, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, OXYPHENBUTAZONE 4-HYDROXYPHENYLBUTAZONE, C19494, D08324, EN300-761427, F82061, Oxyphenbutazone 1000 microg/mL in Acetonitrile, G-27202, J-005659, Q4116192, SR-05000001689-1, SR-05000001689-3, BRD-A33749298-001-05-0
Pubchem:PUBCHEM:4641
Id:82b5b694-3ab0-56b7-b007-4cf5ad681e85
Description:nan
